3,428
Views
22
CrossRef citations to date
0
Altmetric
Article

Feasibility of MRI-guided transurethral ultrasound for lesion-targeted ablation of prostate cancer

ORCID Icon, , ORCID Icon, , , , , , , & show all
Pages 295-302 | Received 22 May 2019, Accepted 23 Aug 2019, Published online: 26 Sep 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Jennifer Le Guevelou, Monica Emilia Chirila, Vérane Achard, Pauline Coralie Guillemin, Orane Lorton, Johannes W. E. Uiterwijk, Giovanna Dipasquale, Rares Salomir & Thomas Zilli. (2022) Combined hyperthermia and radiotherapy for prostate cancer: a systematic review. International Journal of Hyperthermia 39:1, pages 547-556.
Read now
Cameron Wright, Pietari Mäkelä, Mikael Anttinen, Teija Sainio, Peter J. Boström & Roberto Blanco Sequeiros. (2021) Fiducial markers and their impact on ablation outcome for patients treated with MR-guided transurethral ablation (TULSA): a retrospective technical analysis. International Journal of Hyperthermia 38:1, pages 1677-1684.
Read now
Mikael Anttinen, Pietari Mäkelä, Pertti Nurminen, Eemil Yli-Pietilä, Visa Suomi, Teija Sainio, Jani Saunavaara, Pekka Taimen, Roberto Blanco Sequeiros & Peter J. Boström. (2020) Palliative MRI-guided transurethral ultrasound ablation for symptomatic locally advanced prostate cancer. Scandinavian Journal of Urology 54:6, pages 481-486.
Read now
Shiva Madhwan Nair, Noah Stern, Malcolm Dewar, Khurram Siddiqui, Elliot Smith, Jose A. Gomez, Madeleine Moussa & Joseph L. Chin. (2020) Salvage open radical prostatectomy for recurrent prostate cancer following MRI-guided transurethral ultrasound ablation (TULSA) of the prostate: feasibility and efficacy. Scandinavian Journal of Urology 54:3, pages 215-219.
Read now

Articles from other publishers (18)

Mostafa Alabousi, Sangeet Ghai & Masoom A. Haider. (2023) MRI-guided Minimally Invasive Focal Therapies for Prostate Cancer. Radiology 309:3.
Crossref
Pietari Mäkelä, Mikael Anttinen, Cameron Wright, Teija Sainio, Peter J. Boström & Roberto Blanco Sequeiros. (2023) Evolution of non-perfused volume after transurethral ultrasound ablation of prostate: A retrospective 12-month analysis. European Journal of Radiology Open 11, pages 100506.
Crossref
Shima Tayebi, Neha Debnath & Abhinav Sidana. (2023) A Review of Energy Modalities Used for Focal Therapy of Prostate Cancer. Current Surgery Reports 11:12, pages 331-346.
Crossref
Inga Peters, Bennet Hensen, Julian Glandorf, Marcel Gutberlet, Martha Dohna, Steffen Struckmann, Markus Antonius Kuczyk, Frank Wacker & Susanne Hellms. (2023) First experiences using transurethral ultrasound ablation (TULSA) as a promising focal approach to treat localized prostate cancer: a monocentric study. BMC Urology 23:1.
Crossref
Cameron Wright, Pietari Mäkelä, Alexandre Bigot, Mikael Anttinen, Peter J. Boström & Roberto Blanco Sequeiros. (2022) Deep learning prediction of non-perfused volume without contrast agents during prostate ablation therapy. Biomedical Engineering Letters 13:1, pages 31-40.
Crossref
Mostafa Alabousi & Sangeet Ghai. (2023) Magnetic resonance imaging-guided ultrasound ablation for prostate cancer – A contemporary review of performance. Frontiers in Oncology 12.
Crossref
Mikael Anttinen, Roberto Blanco Sequeiros, Peter J. Boström & Pekka Taimen. (2022) Evolving imaging methods of prostate cancer and the emergence of magnetic resonance imaging guided ablation techniques. Frontiers in Oncology 12.
Crossref
Chandler Dora, Gina M. ClarkeGregory FreyDavid Sella. (2022) Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Cancer: A Systematic Review. Journal of Endourology 36:6, pages 841-854.
Crossref
Diyala Samun, Agron Lumiani, Ronald Sroka & Rolf Muschter. (2022) MRI-guided transurethral ultrasound ablation (TULSA) targeted therapy of urinary retention due to benign prostatic obstruction (BPO) and concordant prostate cancer. MRI-guided transurethral ultrasound ablation (TULSA) targeted therapy of urinary retention due to benign prostatic obstruction (BPO) and concordant prostate cancer.
Diyala Samun, Agron Lumiani, Ronald Sroka & Rolf Muschter. (2022) Targeted MRI-guided transurethral ultrasound ablation (TULSA) treatment of prostate cancer and concordant benign prostatic hyperplasia: results of a single-center retrospective study. Targeted MRI-guided transurethral ultrasound ablation (TULSA) treatment of prostate cancer and concordant benign prostatic hyperplasia: results of a single-center retrospective study.
Yvonne Wimper, Jurgen J. Fütterer & Joyce G. R. Bomers. (2022) MR Imaging in Real Time Guiding of Therapies in Prostate Cancer. Life 12:2, pages 302.
Crossref
Antti Viitala, Mikael Anttinen, Cameron Wright, Ilari Virtanen, Pietari Mäkelä, Topi Hovinen, Teija Sainio, Jani Saunavaara, Pekka Taimen, Roberto Blanco Sequeiros & Peter J. Boström. (2021) Magnetic resonance imaging‐guided transurethral ultrasound ablation for benign prostatic hyperplasia: 12‐month clinical outcomes of a phase I study. BJU International 129:2, pages 208-216.
Crossref
Pietari Mäkelä, Mikael Anttinen, Visa Suomi, Aida Steiner, Jani Saunavaara, Teija Sainio, Antero Horte, Pekka Taimen, Peter Boström & Roberto Blanco Sequeiros. (2020) Acute and subacute prostate MRI findings after MRI-guided transurethral ultrasound ablation of prostate cancer. Acta Radiologica 62:12, pages 1687-1695.
Crossref
Agron Lumiani, Diyala Samun, Ronald Sroka & Rolf Muschter. (2021) Single center retrospective analysis of fifty-two prostate cancer patients with customized MR-guided transurethral ultrasound ablation (TULSA). Urologic Oncology: Seminars and Original Investigations 39:12, pages 830.e9-830.e16.
Crossref
Kenneth B. Bader, Samuel A. Hendley & Viktor Bollen. (2021) Assessment of Collaborative Robot (Cobot)-Assisted Histotripsy for Venous Clot Ablation. IEEE Transactions on Biomedical Engineering 68:4, pages 1220-1228.
Crossref
Paulo Priante Kayano & Laurence Klotz. (2021) Current evidence for focal therapy and partial gland ablation for organ-confined prostate cancer: systematic review of literature published in the last 2 years. Current Opinion in Urology 31:1, pages 49-57.
Crossref
Mikael Anttinen, Pietari Mäkelä, Antti Viitala, Pertti Nurminen, Visa Suomi, Teija Sainio, Jani Saunavaara, Pekka Taimen, Roberto Blanco Sequeiros & Peter J. Boström. (2020) Salvage Magnetic Resonance Imaging–guided Transurethral Ultrasound Ablation for Localized Radiorecurrent Prostate Cancer: 12-Month Functional and Oncological Results. European Urology Open Science 22, pages 79-87.
Crossref
Soleen Ghafoor, Anton S. Becker, Daniel Stocker, Borna K. Barth, Daniel Eberli, Olivio F. Donati & Hebert Alberto Vargas. (2020) Magnetic resonance imaging of the prostate after focal therapy with high-intensity focused ultrasound. Abdominal Radiology 45:11, pages 3882-3895.
Crossref